跳至主要内容
临床试验/NCT01411033
NCT01411033进行中(未招募)不适用

Poznan Prospective Study of Type 1 Diabetic Patients Treated With Intensive Insulin Therapy From the Onset of the Disease.

Poznan University of Medical Sciences0 个研究点目标入组 100 人开始时间: 1994年1月最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
100
主要终点
Neuropathy

研究概览

简要总结

The purpose of this study is to evaluate the development and progression of chronic complications (retinopathy, neuropathy, diabetic chronic renal disease, cardiovascular events) in patients with type 1 diabetes treated from the onset of the disease with recommended method of intensive insulin therapy. All patients attended a five-day structured training program during first hospitalization and re-education once year during the observation. After five years of observation and next - once a year chronic complications are assessed. The investigators would like to evaluate also the relationship of the management of the disease, knowledge about the treatment and diabetes, insulin resistance and inflammatory markers with development and progression of chronic complications.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Newly diagnosed type 1 diabetes mellitus with features of complete insulin deficiency (serum C-peptide level <0.05 ng/ml, acetonuria, blood gases disturbances such as: pH <7.30, BE< -6 mmol/l, HCO3 <18 mmol/l)
  • Age < 35 years old
  • Educational course in intensive insulin therapy started at the onset of the disease after treatment of ketoacidosis
  • Written consent

排除标准

  • Uncertain type of diabetes mellitus
  • Kidney failure (serum creatinine level > 1.1 mg/dl)
  • Liver dysfunction (AspAt > 31 U/l, AlAt > 34 U/l)
  • Acute inflammatory process
  • Other concomitant diseases (i.e. neoplasm)

结局指标

主要结局

Neuropathy

时间窗: 1 year

Retinopathy

时间窗: 1 year

Cardiovascular events

时间窗: 1 year

stroke, heart infarct, death

Diabetic chronic renal disease

时间窗: 1 year

次要结局

  • Intima media thickness(1 year)
  • Metabolic management of diabetes(1 year)
  • Quality of life(1 year)

研究者

发起方
Poznan University of Medical Sciences
申办方类型
Other
责任方
Principal Investigator
主要研究者

Aleksandra Uruska

Prof. Dorota Zozulinska -Ziolkiewicz

Poznan University of Medical Sciences

相似试验